1. GBp

    4,556

    Today's change

    39.00 / +0.86%

    1 year change

    +26.12%

    As of Dec 24 2014 12:35 GMT. Data delayed by at least 15 minutes.

Search for AstraZeneca PLC and
  1. December 22, 2014

    Takeover volumes move to highest post-crisis levels

    Corporate takeover deals surged to their highest levels since the financial crisis this year, with merger and acquisition...

  2. December 8, 2014

    Old drugs put under the microscope

    Seven of the world’s biggest drugmakers will invite UK researchers to take a second look at experimental medicines that...

Special Reports

  1. Investing in Britain

    Encouraging signs of health in the UK economy suggest the country is moving into recov...
  2. 50 Top Business Ideas

    The FT puts the spotlight on which inventions and innovations have helped to create to...
Search more Special Reports on this topic.

  1. December 5, 2014

    AstraZeneca wins ‘pay-for-delay’ ruling

    AstraZeneca has avoided a multibillion-dollar damages claim by winning a US court case about deals that seek to delay cheap...

  2. November 25, 2014

    AstraZeneca comes into focus as Pfizer’s cooling-off period ends

    It has been a popular pastime among healthcare investors and pharma executives for weeks: guessing the likelihood of Pfizer...

  3. November 18, 2014

    AstraZeneca fleshes out standalone strategy

    AstraZeneca championed its prospects as a standalone company on Tuesday as it gave more details of its strategy to investors...

  4. November 7, 2014

    UCB caps week of pharma dealmaking

    UCB of Belgium wrapped up another busy week of pharmaceuticals dealmaking on Friday with the $1.5bn disposal of its US...

  5. November 6, 2014

    AstraZeneca: priorities

    $4.20. This little number probably takes up quite a bit of space in the minds of executives at AstraZeneca. Azip, one of the...

  6. November 6, 2014

    AstraZeneca aims to ward off Pfizer by highlighting ‘tax inversion’ risks

    AstraZeneca sought to ward off Pfizer from making a fresh approach for the UK drugmaker by highlighting the increased risk...

  7. November 4, 2014

    Ackman gains ground in fight to force Allergan to sell to Valeant

    Bill Ackman chalked up a big victory in his battle to force Allergan, the maker of blockbuster wrinkle treatment Botox, to...

  8. November 4, 2014

    AstraZeneca strikes deals on cancer drugs

    AstraZeneca struck two deals on Tuesday aimed at strengthening its position in cancer drugs, as the UK pharmaceuticals group...

  9. October 28, 2014

    Pfizer chief: tax inversions still have ‘meaningful value’

    Pfizer has said there is still “meaningful value” to be found in tax inversions despite a White House crackdown that has...

  10. October 24, 2014

    Shire and AstraZeneca show standalone strength

    Britain’s number two and three drugmakers burnished their strength as independent companies on Friday when Shire reported...

  11. October 17, 2014

    Pfizer’s AstraZeneca pursuit knocked by Shire deal collapse

    The chances of Pfizer reviving its pursuit of AstraZeneca have been greatly diminished after the collapse of AbbVie’s £32bn...

  12. October 15, 2014

    Inversions should not (hop) scotch healthy trend for tax competition

    We come not to bury tax inversions but to praise them. The news that US drugs group AbbVie of the US may back out of its...

  13. October 13, 2014

    Renewed merger hopes boost AstraZeneca

    Refreshed hopes of another approach from Pfizer put AstraZeneca back in demand on Monday. AstraZeneca has slipped over the...

  14. October 12, 2014

    Fortune 500 companies spend more than $15bn on corporate responsibility

    US and UK companies in the Fortune Global 500 spend $15.2bn a year on corporate social responsibility (CSR) activities,...

  15. October 9, 2014

    Liverpool School of Tropical Medicine is in a global fight against suffering

    The war on neglected tropical diseases (NTDs) is being fought by “boots on the ground” in the jungles of Africa and Asia....

  16. October 6, 2014

    Gabriel Baertschi’s search for new AstraZeneca premises in Japan

    Just days after his arrival as the new president of AstraZeneca (AZ) in Japan in April 2013, Gabriel Baertschi could feel...

  17. October 5, 2014

    BD agrees to buy CareFusion for $12.2bn

    Becton Dickinson & Co, the medical technology and drug company, has agreed to acquire rival CareFusion for $12.2bn in a cash...

  18. September 30, 2014

    Multibillion cross-border deals make a return after five years

    It may have started in the US in the first few weeks of the year, but the global mergers and acquisitions boom of 2014 has...

  19. September 28, 2014

    Drugs groups trapped in tangled M&A web

    When Valeant offered almost $46bn to buy Allergan in April, it seemed like a large but relatively straightforward deal....

  20. September 26, 2014

    Drug development: Big pharma back in the game it made

    Big pharma is back. That, at least, is the impression created by a wave of new cancer drugs rapidly approaching market....

  21. September 23, 2014

    Curbs on tax inversions fail to convince

    Dissections of a White House plan to curb tax-driven mergers gave way on Tuesday to a realisation that the most significant...

  22. September 23, 2014

    CarMax sputters on disappointing sales

    Shares of CarMax, the largest US used auto dealer, declined on Tuesday after same-store sales nearly flatlined and earnings...

  23. September 23, 2014

    US Treasury hopes to stand logic of tax inversion deals on head

    Taxes may be one of the only two certainties, but tax benefits are very uncertain – as the US Treasury has just...

  24. September 23, 2014

    London stocks hit by US tax crackdown

    London’s equity markets were lower for a second session this week, with drugmakers leading losses after US authorities...

  25. September 16, 2014

    AstraZeneca and Eli Lilly to unite for Alzheimer’s drug challenge

    AstraZeneca has struck a deal to jointly develop a treatment for Alzheimer’s disease with Eli Lilly of the US in a...

  26. September 16, 2014

    AstraZeneca swallows bittersweet pill with Eli Lilly Alzheimer’s deal

    Consciousness, the lens through which humans perceive the world, is ill-adapted for perceiving itself. The paradox is...

  27. September 15, 2014

    Takeover Panel proposes tougher rules for deal promises

    The body that polices UK dealmaking has proposed strengthening its governing Takeover Code to address promises made during...

  28. September 11, 2014

    Pfizer says ‘window still open’ for tax inversions

    Pfizer says the window is still open for US companies to use transatlantic deals to lower their tax rates despite President...

  29. August 31, 2014

    Imperial College London’s new head welcomes political promotion of science

    In the heated debate that followed Pfizer’s attempted takeover of AstraZeneca earlier this year, the government’s attempts...

  30. August 29, 2014

    AstraZeneca gains on renewed bid chatter

    AstraZeneca was among the FTSE 100 leaders on Friday as bid chatter continued to prod the drug company’s shares higher. The...

  31. August 25, 2014

    Chi-Med draws on the past for the future

    Hutchison China MediTech represents the past and the future of China’s pharmaceuticals industry. Much of its revenues come...

  32. August 24, 2014

    Pfizer weighs options on AstraZeneca bid

    Pfizer is considering its acquisition options as a potential path opens this week for the US drugmaker to renew its pursuit...

  33. August 21, 2014

    Drugmaker link-up puts Astra on top

    The UK’s two biggest drugmakers both made it on to the FTSE 100 leaderboard after AstraZeneca developed a partnership that...

  34. August 21, 2014

    Drugmakers help lift FTSE 100

    The FTSE 100’s two biggest drugmakers were on the leaderboard on Thursday after AstraZeneca developed a partnership it hoped...

  35. August 20, 2014

    What next for M&A now the bubble has burst?

    Tuesday August 5 was a bad day for all those hoping the mergers and acquisitions boom had further to run. Investment bankers...

  36. August 19, 2014

    DoJ closes AstraZeneca probe without bringing charges

    US authorities have closed a 10-month investigation into contentious drug trial data surrounding an important AstraZeneca...

  37. August 19, 2014

    AstraZeneca tops FTSE 100

    AstraZeneca made the best single gain on the FTSE 100 on Tuesday after the drug company welcomed news that the US...

  38. August 7, 2014

    Viking raiders will bring Norse sense to company votes

    “From the wrath of the Northmen, oh lord, deliver us,” were the words gabbled by Dark Age peasants in hopes of warding off...

Search for AstraZeneca PLC and

RELATED VIDEOS

Videos from FT.com that closely match this topic

  1. Lex on the rejection of Pfizer's ‘final’ bid...
    May 19, 2014

    Lex on the rejection of Pfizer's ‘final’ bid

  2. The FT debates Pfizer's takeover bid for AstraZeneca...
    May 13, 2014

    The FT debates Pfizer's takeover bid for AstraZeneca

  3. CEO Pascal Soriot on AstraZeneca's move to Cambridge...
    July 3, 2013

    CEO Pascal Soriot on AstraZeneca's move to Cambridge